[HTML][HTML] Tertiary lymphoid structures and B cells: An intratumoral immunity cycle

WH Fridman, M Meylan, G Pupier, A Calvez… - Immunity, 2023 - cell.com
The generation of anti-tumor immunity in the draining lymph nodes is known as the cancer
immunity cycle. Accumulating evidence supports the occurrence of such a cycle at tumor …

Targeting the tumour vasculature: from vessel destruction to promotion

S Guelfi, K Hodivala-Dilke, G Bergers - Nature Reviews Cancer, 2024 - nature.com
As angiogenesis was recognized as a core hallmark of cancer growth and survival, several
strategies have been implemented to target the tumour vasculature. Yet to date, attempts …

T follicular helper cells in cancer

N Gutiérrez-Melo, D Baumjohann - Trends in cancer, 2023 - cell.com
T follicular helper (Tfh) cells provide essential help to B cells for effective antibody-mediated
immune responses. Although the crucial function of these CD4+ T cells in infection and …

Tertiary lymphoid structures in anticancer immunity

JL Teillaud, A Houel, M Panouillot, C Riffard… - Nature Reviews …, 2024 - nature.com
Tertiary lymphoid structures (TLS) are transient ectopic lymphoid aggregates where
adaptive antitumour cellular and humoral responses can be elaborated. Initially described in …

TGF-β signaling networks in the tumor microenvironment

MKK Chan, JYF Chung, PCT Tang, ASW Chan, JYY Ho… - Cancer letters, 2022 - Elsevier
Transforming growth factor-β (TGF-β) signaling shows important roles in both physiology
and pathology, especially in the progression of inflammatory diseases including cancer …

Targeting intracellular oncoproteins with dimeric IgA promotes expulsion from the cytoplasm and immune-mediated control of epithelial cancers

S Biswas, G Mandal, CM Anadon, RA Chaurio… - Immunity, 2023 - cell.com
Dimeric IgA (dIgA) can move through cells via the IgA/IgM polymeric immunoglobulin
receptor (PIGR), which is expressed mainly on mucosal epithelia. Here, we studied the …

Tertiary lymphoid structures in diseases: immune mechanisms and therapeutic advances

L Zhao, S Jin, S Wang, Z Zhang, X Wang… - … and Targeted Therapy, 2024 - nature.com
Tertiary lymphoid structures (TLSs) are defined as lymphoid aggregates formed in non-
hematopoietic organs under pathological conditions. Similar to secondary lymphoid organs …

T Follicular Helper Cell Heterogeneity

W Song, J Craft - Annual Review of Immunology, 2023 - annualreviews.org
T follicular helper (Tfh) cells specialize in helping B cells and are therefore critical
contributors to the generation of humoral immunity. Tfh cells aid immunoglobulin class …

Escherichia coli–Specific CXCL13-Producing TFH Are Associated with Clinical Efficacy of Neoadjuvant PD-1 Blockade against Muscle-Invasive Bladder Cancer

AG Goubet, L Lordello, C Alves Costa Silva, I Peguillet… - Cancer discovery, 2022 - AACR
Biomarkers guiding the neoadjuvant use of immune-checkpoint blockers (ICB) are needed
for patients with localized muscle-invasive bladder cancers (MIBC). Profiling tumor and …

High endothelial venules in cancer: regulation, function, and therapeutic implication

G Vella, Y Hua, G Bergers - Cancer Cell, 2023 - cell.com
The lack of sufficient intratumoral CD8+ T lymphocytes is a significant obstacle to effective
immunotherapy in cancer. High endothelial venules (HEVs) are organ-specific and …